FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

27 results

alendronate
(ALENDRONATE SODIUM)
Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd.
Usage: Alendronate sodium tablets are indicated for treating and preventing osteoporosis in postmenopausal women, increasing bone mass in men with osteoporosis, treating glucocorticoid-induced osteoporosis, and treating Paget’s disease of bone. Use should be periodically re-evaluated, particularly for low-risk fracture patients after 3 to 5 years.
alendronate
(Alendronate sodium tablet)
Marlex Pharmaceuticals Inc
Usage: Alendronate sodium is indicated for treating osteoporosis in postmenopausal women, increasing bone mass in men with osteoporosis, preventing postmenopausal osteoporosis, treating glucocorticoid-induced osteoporosis, and managing Paget's disease of bone in symptomatic patients or those at risk for complications. Reinforcement of therapy need is recommended periodically.
alendronate sodium
(Alendronate Sodium)
Hikma Pharmaceuticals USA Inc.
Usage: Alendronate sodium is indicated for the treatment of osteoporosis in postmenopausal women and to increase bone mass in men with osteoporosis. It reduces fracture incidence, though the optimal treatment duration hasn't been established, requiring periodic re-evaluation of the need for continued therapy.
calcitonin salmon
(Calcitonin Salmon)
ENDO USA, Inc.
Usage: Calcitonin salmon injection is indicated for treating symptomatic Paget's disease of bone, hypercalcemic emergencies, and postmenopausal osteoporosis in patients who cannot use alternative therapies. Its efficacy in fracture reduction for osteoporosis is not established, and ongoing therapy should be periodically re-evaluated due to potential malignancy risks.
calcitonin salmon
(CALCITONIN SALMON)
Cipla USA Inc.
Usage: Calcitonin salmon injection is indicated for treating symptomatic Paget’s disease of bone, hypercalcemic emergencies, and postmenopausal osteoporosis in women more than five years postmenopause. It is intended for patients who do not respond to, or cannot use, alternative treatments. Regular re-evaluation is recommended due to potential malignancy risks.
duavee
(conjugated estrogens/bazedoxifene)
Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
Usage: DUAVEE is indicated for women with a uterus to treat moderate to severe menopausal vasomotor symptoms and to prevent postmenopausal osteoporosis. Treatment duration should be minimal and reconsidered periodically, focusing on women at significant risk of osteoporosis.
estradiol and norethindrone acetate
(Estradiol and Norethindrone Acetate)
Ingenus Pharmaceuticals, LLC
Usage: Estradiol and norethindrone acetate tablets are indicated for the treatment of moderate to severe vasomotor symptoms and vulvar/vaginal atrophy due to menopause, as well as for the prevention of postmenopausal osteoporosis in women at significant risk. Topical alternatives should be considered for certain conditions.
etyqa
(ESTRADIOL AND NORETHINDRONE ACETATE)
Aurobindo Pharma Limited
Usage: Etyqa is indicated for the treatment of moderate to severe vasomotor symptoms and vulvar/vaginal atrophy due to menopause, as well as for the prevention of postmenopausal osteoporosis in women at significant risk. Topical products are preferred for vaginal atrophy, and non-estrogen options are recommended for osteoporosis.
evenity
(romosozumab-aqqg)
Amgen Inc
Usage: EVENITY is indicated for the treatment of osteoporosis in postmenopausal women at high fracture risk, including those with a history of fractures or multiple risk factors, or those intolerant to other therapies. Limitation: use is restricted to 12 monthly doses due to waning effectiveness.
fyavolv
(Norethindrone Acetate and Ethinyl Estradiol)
Lupin Pharmaceuticals, Inc.
Usage: This drug is indicated for the treatment of moderate to severe vasomotor symptoms associated with menopause and the prevention of postmenopausal osteoporosis. However, estrogen therapy should only be considered for osteoporosis in women at significant risk, with non-estrogen options preferred.

Medications for Osteoporosis Postmenopausal

alendronate

alendronate

alendronate sodium

calcitonin salmon

calcitonin salmon

duavee

estradiol and norethindrone acetate

etyqa

evenity

fyavolv